Evidence map›Paper›PMID 24234733›Full record

SynthesisObesity surgery2014

Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review.

Usha K Coblijn, Amin B Goucham, Sjoerd M Lagarde, Sjoerd D Kuiken, Bart A van Wagensveld

2 registry-linked trialsAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Obesity surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 90 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 9 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05799105 phase4recruitingnot on this mapstarted 2023, after this paper: background citation

OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers After Bariatric Surgery

TypeinterventionalSponsorStephen FirkinsRan2023 to 2027Enrolled122ConditionsMarginal UlcerArmsOmeprazole 40 milligrams
NCT06543316 narecruitingnot on this mapstarted 2025, after this paper: background citation

Accelerated Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment

TypeinterventionalSponsorChristopher C. Thompson, MD, MScRan2025 to 2028Enrolled100ConditionsRoux-en-y Anastomosis Site, Marginal Ulcer, Marginal Ulcer (Peptic) or Erosion, UlcerArmsLow Thermal Plasma (LTP) Treatment, Standard of Care Ulcer Treatment (typically PPI Administration)
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 9 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Predictors of marginal ulcer after gastric bypass: a systematic review and meta-analysis.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Guideline
  8. Medical versus surgical treatment for refractory or recurrent peptic ulcer.The Cochrane database of systematic reviews · 2016
    Pooled it
  9. Is antisecretory therapy after pancreatoduodenectomy necessary? Meta-analysis and contemporary practices of pancreatic surgeons.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2015
    Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Usha K Coblijn
Amin B Goucham
Sjoerd M Lagarde
Sjoerd D Kuiken
Bart A van Wagensveld
Sint Lucas Andreas Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laparoscopic Roux-en-Y gastric bypass (LRYGB) is the gold standard in bariatric surgery. A long-term complication can be marginal ulceration (MU) at the gastrojejunostomy. The mechanism of development is unclear and symptoms vary. Management and prevention is a continuous subject of debate. The aim was to assess the incidence, mechanism, symptoms, and management of MU after LRYGB by means of a systematic review. Forty-one studies with a total of 16,987 patients were included, 787 (4.6%) developed MU. The incidence of MU varied between 0.6 and 25%. The position and size of the pouch, smoking, and nonsteroidal inflammatory drugs usage are associated with the formation of MU. In most cases, MU is adequately treated with proton pump inhibitors, sometimes reoperation is required. Laparoscopic approach is safe and effective.

Indexed as

Gastric BypassLaparoscopyCardiovascular DiseasesDiabetes Mellitus, Type 2FemaleHumansIncidenceMaleObesity, MorbidPostoperative ComplicationsProton Pump InhibitorsRisk FactorsSmokingStomach UlcerProton Pump Inhibitors

Identifiers

PMID24234733
OpenAlexW2076048393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.